These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 6347783)

  • 1. The bioavailability of circulating antibody-bound insulin following insulin withdrawal in Type 1 (insulin-dependent) diabetes.
    Vaughan NJ; Matthews JA; Kurtz AB; Nabarro JD
    Diabetologia; 1983 May; 24(5):355-8. PubMed ID: 6347783
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The relationship between circulating free and bound insulin, insulin antibodies, insulin dosage and diabetic control in insulin treated diabetics.
    Asplin CM; Hartog M; Goldie DJ
    Acta Endocrinol (Copenh); 1978 Feb; 87(2):330-8. PubMed ID: 580135
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The influence of insulin antibody levels on the plasma profiles and action of subcutaneously injected human and bovine short acting insulins.
    Francis AJ; Hanning I; Alberti KG
    Diabetologia; 1985 Jun; 28(6):330-4. PubMed ID: 3899818
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insulin effect in chronic alcoholics during alcohol withdrawal.
    Adner N; Nygren A
    Diabetologia; 1982 Mar; 22(3):215-6. PubMed ID: 7042432
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Dynamics of free, total and antibody-bound insulin in diabetes mellitus patients in the process of treatment with swine insulin].
    Pliats OM; Alekseev IuP
    Probl Endokrinol (Mosk); 1977; 23(2):3-6. PubMed ID: 561956
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety of continuous subcutaneous insulin infusion: metabolic deterioration and glycaemic autoregulation after deliberate cessation of infusion.
    Pickup JC; Viberti GC; Bilous RW; Keen H; Alberti KG; Home PD; Binder C
    Diabetologia; 1982 Mar; 22(3):175-9. PubMed ID: 7042428
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Free, total and antibody-bound insulin content in newly detected diabetes mellitus patients].
    Mosin VI; Morozova NN; Salanda BS
    Probl Endokrinol (Mosk); 1980; 26(5):6-11. PubMed ID: 7001439
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diurnal variation of blood ketone bodies in insulin-dependent diabetes mellitus and noninsulin-dependent diabetes mellitus patients: the relationship to serum C-peptide immunoreactivity and free insulin.
    Ubukata E
    Ann Nutr Metab; 1990; 34(6):333-42. PubMed ID: 2076025
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prolonged action of regular insulin in diabetic patients: lack of relationship to circulating insulin antibodies.
    Gardner DF; Wilson HK; Podet EJ; Arakaki RF; Nell LJ; Thomas JW; Crane MM; Field JB
    J Clin Endocrinol Metab; 1986 Apr; 62(4):621-7. PubMed ID: 3512590
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of diet on intermediary metabolite concentrations in Type 2 (non-insulin-dependent) diabetes mellitus.
    Sheppard MC; Burrin J; Alberti KG; Nattrass M
    Diabetologia; 1983 May; 24(5):333-5. PubMed ID: 6873512
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A prospective study of glucose profiles, insulin antibody levels and beta cells secretory patterns in non-obese Ugandan diabetic subjects.
    Otim MA
    East Afr Med J; 1988 Jan; 65(1):8-15. PubMed ID: 3046922
    [No Abstract]   [Full Text] [Related]  

  • 12. The metabolic response to insulin deprivation in idiopathic brittle diabetes.
    Husband DJ; Pernet A; Gill GV; Hanning I; Alberti KG
    Diabetes Res; 1986 May; 3(4):193-8. PubMed ID: 3527516
    [TBL] [Abstract][Full Text] [Related]  

  • 13. U-100 insulin gives some protection against metabolic deterioration due to CSII interruption.
    Scheen AJ; Henrivaux P; Jandrain B; Lefèbvre PJ
    Diabetes Care; 1987; 10(6):707-11. PubMed ID: 3322727
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of insulin withdrawal on intermediary metabolism in patients with diabetes secondary to chronic pancreatitis.
    Larsen S; Hilsted J; Philipsen EK; Tronier B; Damkjaer Nielsen M; Worning H
    Acta Endocrinol (Copenh); 1991 May; 124(5):510-5. PubMed ID: 2028708
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glucose metabolism during the starved-to-fed transition in obese patients with NIDDM.
    Féry F; Balasse EO
    Diabetes; 1994 Dec; 43(12):1418-25. PubMed ID: 7958493
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A 6-hour nocturnal interruption of a continuous subcutaneous insulin infusion: 1. Metabolic and hormonal consequences and scheme for a prompt return to adequate control.
    Krzentowski G; Scheen A; Castillo M; Luyckx AS; Lefèbvre PJ
    Diabetologia; 1983 May; 24(5):314-8. PubMed ID: 6347779
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of oral alanine on blood beta-hydroxybutyrate and plasma glucose, insulin, free fatty acids, and growth hormone in normal and diabetic subjects.
    Genuth SM; Castro J
    Metabolism; 1974 Apr; 23(4):375-86. PubMed ID: 4206148
    [No Abstract]   [Full Text] [Related]  

  • 18. Glucose utilization during exercise in normal and diabetic subjects. The role of insulin.
    Krzentowski G; Pirnay F; Pallikarakis N; Luyckx AS; Lacroix M; Mosora F; Lefèbvre PJ
    Diabetes; 1981 Dec; 30(12):983-9. PubMed ID: 7030833
    [No Abstract]   [Full Text] [Related]  

  • 19. Determination of free and antibody-bound insulin in insulin treated diabetic patients.
    Heding LG
    Horm Metab Res; 1969 May; 1(3):145-6. PubMed ID: 5408729
    [No Abstract]   [Full Text] [Related]  

  • 20. Change of insulin dosage, circulating free and bound insulin and insulin antibodies on transferring diabetics from conventional to highly purified porcine insulin.
    Asplin CM; Hartog M; Goldie DJ
    Diabetologia; 1978 Feb; 14(2):99-105. PubMed ID: 631462
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.